SCHEMBL9428554

SCHEMBL9428554

COC(=O)c1noc(-c2ccccc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.50
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
RORC P51449 1/20 0.48
TRPV1 Q8NER1 5/20 0.48
MAPT P10636 3/20 0.45
CISD2 Q8N5K1 1/20 0.44
GMNN O75496 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
THRB P10828 1/20 0.44
PIM1 P11309 1/20 0.44
CYP2C9 P11712 1/20 0.44
MAOA P21397 1/20 0.44
SLC6A2 P23975 1/20 0.44
HTR2A P28223 1/20 0.44
AGTR1 P30556 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9429341 0.90 MAPT (0.58) NPC1RAB9ARORCTRPV1MAPT
SCHEMBL9429463 0.88 PTGS2 (0.52) PTGS1RORCTRPV1TP53HTT
SCHEMBL9429412 0.85 HIF1A (0.56) PTGS1NPC1RAB9AMAPTLMNA
SCHEMBL9428463 0.85 KDM4E (0.54) PTGS1NPC1RAB9ARORCMAPT
SCHEMBL9428482 0.83 HTT (0.54) NPC1RAB9ATRPV1MAPTCISD2
SCHEMBL9429300 0.79 SMN1; SMN2 (0.52) RORCTRPV1TP53HTTSMN1; SMN2
SCHEMBL9428655 0.79 PTGS2 (0.51) NPC1RAB9ATRPV1MAPTTP53
SCHEMBL9429262 0.77 PTGS2 (0.49) NPC1RAB9ATRPV1MAPTGMNN
SCHEMBL9429668 0.77 HIF1A (0.57) PTGS1NPC1RAB9AMAPTLMNA
SCHEMBL1806543 0.76 PTGS1 (0.55) PTGS1TRPV1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed